Detalles de la búsqueda
1.
CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma.
Future Oncol
; 18(8): 915-926, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911359
2.
Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review.
Cancer Treat Rev
; 122: 102652, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980876
3.
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.
Lung Cancer
; 98: 84-90, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27393512
Resultados
1 -
3
de 3
1
Próxima >
>>